Author Archives for Laureline Nourris

DigitalforLife: Digital enterprises, meet health challenges

On May 28th, at the Ecole des Mines de Nantes, the fourth Digital & Health day took place. It was... View Article

Rédigé par Laureline Nourris, le 2015-08-20

DigitalforLife: Digital enterprises, meet health challenges

On May 28th, at the Ecole des Mines de Nantes, the fourth Digital & Health day took place. It was... View Article

Hemarina, 1er prix du Concours des Technologies Médicales Innovantes

L’entreprise Hemarina, accompagnée par ID2Santé et membre d’Atlanpole Biotherapies, est lauréate du Concours TMI 2015 organisé par l’Alliance pour le... View Article

AAA Signs Distribution Agreement for Lutathera in Japan with FUJIFILM RI Pharma, Co., LTD

Advanced Accelerator Applications S.A., an international specialist in Molecular Nuclear Medicine (MNM) and member of Atlanpole Biotherapies, announce s that... View Article

Rédigé par Laureline Nourris, le 2015-08-20

AAA Signs Distribution Agreement for Lutathera in Japan with FUJIFILM RI Pharma, Co., LTD

Advanced Accelerator Applications S.A., an international specialist in Molecular Nuclear Medicine (MNM) and member of Atlanpole Biotherapies, announce s that... View Article

Press Release BIOMATLANTE obtains CE approval to market its OSTEOTWIN™ Affix Sheath

BIOMATLANTE (Vigneux de Bretagne ), a medical devices company specialized in bone regeneration and member of Atlanpole Biotherapies, today announced... View Article

Rédigé par Laureline Nourris, le 2015-08-20

Press Release BIOMATLANTE obtains CE approval to market its OSTEOTWIN™ Affix Sheath

BIOMATLANTE (Vigneux de Bretagne ), a medical devices company specialized in bone regeneration and member of Atlanpole Biotherapies, today announced... View Article

Program IHU CESTI: StemHepTher, promising alternatives to liver transplantation

Many types of diseases, whether of genetic origin or not, present a severe dysfunction or generalized dysfunctions of the liver,... View Article

Rédigé par Laureline Nourris, le 2015-08-20

Program IHU CESTI: StemHepTher, promising alternatives to liver transplantation

Many types of diseases, whether of genetic origin or not, present a severe dysfunction or generalized dysfunctions of the liver,... View Article